News

Moderna Receives European Commission Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1
CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...
US rejection of mRNA vaccines shows ‘lack of respect for science,’ says Nobel laureate
The Nobel Prize winning scientist behind mRNA vaccine technology has attacked the US health secretary’s plan to effectively ...
USA Today4y
Moderna COVID-19 vaccine 94.5% effective, similar to Pfizer: Trial
Moderna's candidate COVID-19 vaccine is even more effective than Pfizer's, trial results show, a "light at the end of the tunnel" for the pandemic.
CNN3y
Moderna says its Covid-19 vaccine performs as well in children as it ...
Moderna also announced that it has initiated a submission to the FDA for emergency use authorization of the company’s Covid-19 vaccine for children ages 6 through 11 years old. Children that age ...
Los Angeles Times4y
Moderna vaccine protects against COVID for months, company says - Los ...
COVID vaccine maker Pfizer Inc. lost 0.6%, while its partner BioNTech, shed 3.8%. Moderna’s latest efficacy data hasn’t been published in a medical journal and further details weren’t released.
The New York Times4y
Moderna's Covid-19 Vaccine, Explained - The New York Times
Moderna’s Covid Vaccine: What You Need to Know Denise Grady Published Nov. 16, 2020 Updated Nov. 30, 2020 Share full article ...
MedPage Today1d
Did FDA Pick the Wrong COVID Vaccine Strain Last Season? | MedPage Today
In Danes over age 65, the vaccine effectiveness of the JN.1-based mRNA boosters reached 70-85% against COVID-related hospitalization and 76-96% against COVID-associated death. Despite the shift away ...
'More risks than benefits': RFK Jr shuts down $500 Million mRNA vaccine projects; programs credited with saving millions during Covid
US health and human services secretary Robert F Kennedy Jr announced Tuesday the US federal government is canceling around ...